In a recent development, the newly established California Office of Health Care Affordability (OHCA) has made further revisions to the proposed regulations for pre-closing reviews of health care transactions. This is preparatory to commencing advanced regulatory reviews of certain health care transactions, effective from January 1, 2024. The information was made known by Mintz – Health Care Viewpoints on JD Supra.
The incorporation of pre-closing reviews by the OHCA is a significant move affecting a wide range of health care entities. These entities, with few exceptions, will be subject to prospective transaction reviews. This move is seen as a strategy to enhance transparency and accountability within the healthcare sector, ensuring affordability and standardization of healthcare services to Californians.
Given the implications of these developments on healthcare transaction operations, stakeholders and legal professionals within healthcare entities are advised to familiarize themselves with the upcoming changes. This will aid navigation through the new system, thus ensuring compliance while maintaining efficiency in their transactions.
The OHCA is expected to send the updated proposed regulations to the Office of Administrative Law shortly. Keeping an eye on these developments will be crucial to keeping practices up to date and in line with the new standards and regulations.
For more detailed insight and understanding of this proposed change, the original article can be accessed here.